Skip to main content

Articles By Jack Cush, MD

RheumNow Podcast square

The Inflammation Reflex (5.20.2022)

By Jack Cush, MD
20 May 2022

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week, neuroimmunology leading to therapy, the cold shoulder approach and Regulatory updates from the FDA.

Read Article
psoriatic.PIP_.JPG

Biologic Persistence in Psoriatic Arthritis and Psoriasis

By Jack Cush, MD
19 May 2022

Two recent studies examined the durability and persistence of biologic agents in patients with psoriasis (PSO) and psoriatic arthritis (PsA) and while some differences were noted overall persistence was low 3 years later.

Read Article
Inflammation,reflex,neural

Inflammatory Arthritis Spread by ATP and Neural Crosstalk

By Jack Cush, MD
19 May 2022

A novel study from the Journal of Experimental Medicine suggests that a reflex neural signaling at sites of inflammation may lead to spread to other inflammatory sites via and ATP-mediated neural crosstalk.

Read Article
PSS.hands_.Raynauds.jpg (keep)

Relevance of Raynaud’s in Systemic Sclerosis

By Jack Cush, MD
18 May 2022

Raynaud’s phenomenon (RP) is integral to the diagnosis and management of systemic sclerosis (SSc) patients; a recent analysis suggests that RP should be characterized based on color change and the presence of other symptoms to know whether RP portends more serious manifestations.

Read Article
SpA,RNL,2022

RNL 2022: Spondyloarthritis Spectrum

By Jack Cush, MD
18 May 2022

This RheumNow Live 2022 session features highlights from lectures on Spondyloarthritis. - Microbiome in Spondyloathritis - Jose Scher, MD - Axial Psoriatic Arthritis - Philip Mease, MD - Juvenile Spondyloathritis - Pamela Weiss, MD

Read Article
Malar,rash,SLE, Lupus

Rising Incidence of Systemic Lupus Erythematosus

By Jack Cush, MD
17 May 2022

Data from Olmstead county, MN over the past four decades shows that the incidence and prevalence of systemic lupus erythematosus (SLE) is increasing. SLE was diagnosed using the EULAR/ACR criteria and looked at patients seen between 1976–2018.

Read Article
morbidity,covid,heart,lung,brain

Multimorbidity Burden in Rheumatoid Arthritis

By Jack Cush, MD
17 May 2022

Crowson and colleagues at the Mayo Clinic have shown that rheumatoid arthritis (RA) patients have a higher prevalence of multimorbidity with as many as 44 different morbidities of interest in RA.

Read Article
lumbar,spine,lbp,pain

Acute Inflammatory Responses Needed to Resolve Chronic Pain

By Jack Cush, MD
16 May 2022

Science Translational Medicine has published results of a Canadian study of low back pain (LBP) suggests that pain control by anti-inflammatory treatments might have negative effects on pain duration and may be counterproductive for long-term pain outcomes.

Read Article
FDA.Safety.jpg

Bimekizumab Development Delayed by FDA

By Jack Cush, MD
16 May 2022

UCB announced they have received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Biologics License Application (BLA) for bimekizumab for the treatment of adults with moderate to severe plaque psoriasis (PSO).

Read Article
RheumNow Podcast square

Methotrexate Monitoring (5.13.2022)

By Jack Cush, MD
13 May 2022

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Bad news for digitial ulcers in Systemic sclerosis, Readmissions in Lupus and Thrombocytopenia in APL patients.

Read Article
×